Table 2.

Empiric Antibiotic Regimens in 43 Patients with Positive Biopsies

Antibiotic(s)	n (%)
Vancomycin	14 (32.6)
Vancomycin + ceftriaxone	6 (14.0)
Vancomycin + oxacillin	3 (7.0)
Ciprofloxacin	3 (7.0)
Vancomycin + cefazolin	2 (4.7)
Vancomycin + ampicillin/sulbactam	2 (4.7)
Vancomycin + ciprofloxacin	2 (4.7)
Others	11 (25.6)

NOTE. Others are (all n = 1): oxacillin; ceftriaxone; linezolid; azithromycin; cefepime + gentamicin; ampicillin/sulbactam + cefepime; vancomycin + rifampin; ciprofloxacin + rifampin; vancomycin + cefepime + amikacin; vancomycin + gentamicin + levofloxacin; vancomycin + cefepime. The data are from 43 patients who had positive needle or open biopsies despite previous antibiotic exposure; this is a subgroup of 61 culture-positive cases in our 92 biopsied patients.